IRIS Archives

Information and Referral and Internet Sightings

IRIS@LISTSERV.ICORS.ORG
Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Condense Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Mime-Version:
1.0
Sender:
Information and Referral and Internet Sightings <[log in to unmask]>
Subject:
FDA Approves Latuda to Treat Schizophrenia in Adults
From:
Sylvia Caras <[log in to unmask]>
Date:
Mon, 1 Nov 2010 14:27:52 -0700
Message-ID:
<[log in to unmask]>
Content-Type:
text/plain; charset="us-ascii"; format=flowed
Reply-To:
[log in to unmask]
Parts/Attachments:
text/plain (15 lines) 
FDA Approves Latuda to Treat Schizophrenia in Adults

 From the PharmaLive.com News Archive - Oct. 28, 2010

The FDA today approved Latuda (lurasidone HCl) tablets for the 
treatment of adults with schizophrenia. Latuda is included in the 
atypical antipsychotic class of drugs. All atypical antipsychotics 
contain a boxed warning alerting prescribers to an increased risk of 
death associated with off-label use of these drugs to treat 
behavioral problems in older people with dementia-related psychosis. 
No drug in this class is approved to treat patients with 
dementia-related psychosis.

www.peoplewho.org

ATOM RSS1 RSS2